These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35278208)

  • 1. Systems-Level Analysis of Genetic Variants Reveals Functional and Spatiotemporal Context in Treatment-resistant Schizophrenia.
    Talarico F; Costa GO; Ota VK; Santoro ML; Noto C; Gadelha A; Bressan R; Azevedo H; Belangero SI
    Mol Neurobiol; 2022 May; 59(5):3170-3182. PubMed ID: 35278208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia.
    Wimberley T; Gasse C; Meier SM; Agerbo E; MacCabe JH; Horsdal HT
    Schizophr Bull; 2017 Sep; 43(5):1064-1069. PubMed ID: 28184875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk scores for schizophrenia and treatment resistance: New data, systematic review and meta-analysis.
    Facal F; Costas J
    Schizophr Res; 2023 Feb; 252():189-197. PubMed ID: 36657363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
    Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
    JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia.
    O'Connell KS; Koch E; Lenk HÇ; Akkouh IA; Hindley G; Jaholkowski P; Smith RL; Holen B; Shadrin AA; Frei O; Smeland OB; Steen NE; Dale AM; Molden E; Djurovic S; Andreassen OA
    Psychiatry Res; 2023 Jul; 325():115217. PubMed ID: 37146461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
    Hettige NC; Cole CB; Khalid S; De Luca V
    Schizophr Res; 2016 Feb; 170(2-3):265-70. PubMed ID: 26778674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
    Li J; Yoshikawa A; Brennan MD; Ramsey TL; Meltzer HY
    Schizophr Res; 2018 Feb; 192():194-204. PubMed ID: 28431800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.
    Pergola G; Di Carlo P; D'Ambrosio E; Gelao B; Fazio L; Papalino M; Monda A; Scozia G; Pietrangelo B; Attrotto M; Apud JA; Chen Q; Mattay VS; Rampino A; Caforio G; Weinberger DR; Blasi G; Bertolino A
    Transl Psychiatry; 2017 Jan; 7(1):e1006. PubMed ID: 28094815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Facal F; Arrojo M; Paz E; Páramo M; Costas J
    Acta Psychiatr Scand; 2022 Aug; 146(2):139-150. PubMed ID: 35582973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing the genetic architecture of treatment-resistant schizophrenia in East Asian ancestry.
    Lim K; Yee JY; See YM; Ng BT; Zheng S; Tang C; Lencz T; Lee J; Lam M
    Asian J Psychiatr; 2023 Dec; 90():103826. PubMed ID: 37944474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain.
    Radulescu E; Jaffe AE; Straub RE; Chen Q; Shin JH; Hyde TM; Kleinman JE; Weinberger DR
    Mol Psychiatry; 2020 Apr; 25(4):791-804. PubMed ID: 30478419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia.
    Gasse C; Wimberley T; Wang Y; Mors O; Børglum A; Als TD; Werge T; Nordentoft M; Hougaard DM; Horsdal HT
    Schizophr Res; 2019 Oct; 212():79-85. PubMed ID: 31447354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort.
    Santoro ML; Ota V; de Jong S; Noto C; Spindola LM; Talarico F; Gouvea E; Lee SH; Moretti P; Curtis C; Patel H; Newhouse S; Carvalho CM; Gadelha A; Cordeiro Q; Bressan RA; Belangero SI; Breen G
    Transl Psychiatry; 2018 Aug; 8(1):174. PubMed ID: 30171181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of relevant hub genes for early intervention at gene coexpression modules with altered predicted expression in schizophrenia.
    Rodriguez-López J; Arrojo M; Paz E; Páramo M; Costas J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109815. PubMed ID: 31715283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA Differences Related to Treatment-Resistant Schizophrenia.
    Pérez-Rodríguez D; Penedo MA; Rivera-Baltanás T; Peña-Centeno T; Burkhardt S; Fischer A; Prieto-González JM; Olivares JM; López-Fernández H; Agís-Balboa RC
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Structural Covariance Network and Antipsychotic Treatment Response in Schizophrenia.
    Tsugawa S; Honda S; Noda Y; Wannan C; Zalesky A; Tarumi R; Iwata Y; Ogyu K; Plitman E; Ueno F; Mimura M; Uchida H; Chakravarty M; Graff-Guerrero A; Nakajima S
    Schizophr Bull; 2024 Mar; 50(2):382-392. PubMed ID: 37978044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel functional brain proteins for treatment-resistant schizophrenia: Based on a proteome-wide association study.
    Wei W; Zhang H; Cheng B; Qin X; He D; Zhang N; Zhao Y; Cai Q; Shi S; Chu X; Wen Y; Liu H; Jia Y; Zhang F
    Eur Psychiatry; 2023 Apr; 66(1):e33. PubMed ID: 37055858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
    Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S
    Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk scores in schizophrenia with clinically significant copy number variants.
    Taniguchi S; Ninomiya K; Kushima I; Saito T; Shimasaki A; Sakusabe T; Momozawa Y; Kubo M; Kamatani Y; Ozaki N; Ikeda M; Iwata N
    Psychiatry Clin Neurosci; 2020 Jan; 74(1):35-39. PubMed ID: 31461559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.